Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mourad Tighiouart

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Journal of the Royal Statistical Society. Series C, Applied Statistics|February 13, 2019
Two-stage design for phase I-II cancer clinical trials using continuous dose combinations of cytotoxic agentsMourad Tighiouart
Entropy (Basel, Switzerland)|August 29, 2024
Dose Finding in Oncology Trials Guided by Ordinal Toxicity Grades Using Continuous Dose LevelsMourad Tighiouart, André Rogatko
Journal of the Royal Statistical Society. Series C, Applied Statistics|February 13, 2023
Combining cytotoxic agents with continuous dose levels in seamless phase I-II clinical trialsJosé L Jiménez, Mourad Tighiouart
Journal of Biopharmaceutical Statistics|November 17, 2025
A Bayesian design for dual-agent dose optimization with targeted therapiesJosé L Jiménez, Mourad Tighiouart
Plos One|March 26, 2014
Escalation with overdose control using time to toxicity for cancer phase I clinical trialsMourad Tighiouart, Yuan Liu, André Rogatko
Contemporary Clinical Trials|May 8, 2012
Dose escalation with overdose control using a quasi-continuous toxicity score in cancer Phase I clinical trialsZhengjia Chen, Mourad Tighiouart, Jeanne Kowalski
Statistics in Medicine|April 11, 2016
A Bayesian adaptive design for estimating the maximum tolerated dose curve using drug combinations in cancer phase I clinical trialsMourad Tighiouart, Quanlin Li, André Rogatko
Statistics in Medicine|May 15, 2014
Dose finding with drug combinations in cancer phase I clinical trials using conditional escalation with overdose controlMourad Tighiouart, Steven Piantadosi, André Rogatko
Oral Oncology|April 9, 2008
Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanomaNicolas McLean, Mourad Tighiouart, Susan Muller
Stats|October 19, 2020
A Bayesian Adaptive Design in Cancer Phase I Trials Using Dose Combinations with Ordinal Toxicity GradesMárcio A Diniz, Sungjin Kim, Mourad Tighiouart
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Journal of the Royal Statistical Society. Series C, Applied Statistics|February 13, 2019
Two-stage design for phase I-II cancer clinical trials using continuous dose combinations of cytotoxic agentsMourad Tighiouart
Entropy (Basel, Switzerland)|August 29, 2024
Dose Finding in Oncology Trials Guided by Ordinal Toxicity Grades Using Continuous Dose LevelsMourad Tighiouart, André Rogatko
Journal of the Royal Statistical Society. Series C, Applied Statistics|February 13, 2023
Combining cytotoxic agents with continuous dose levels in seamless phase I-II clinical trialsJosé L Jiménez, Mourad Tighiouart
Journal of Biopharmaceutical Statistics|November 17, 2025
A Bayesian design for dual-agent dose optimization with targeted therapiesJosé L Jiménez, Mourad Tighiouart
Plos One|March 26, 2014
Escalation with overdose control using time to toxicity for cancer phase I clinical trialsMourad Tighiouart, Yuan Liu, André Rogatko
Contemporary Clinical Trials|May 8, 2012
Dose escalation with overdose control using a quasi-continuous toxicity score in cancer Phase I clinical trialsZhengjia Chen, Mourad Tighiouart, Jeanne Kowalski
Statistics in Medicine|April 11, 2016
A Bayesian adaptive design for estimating the maximum tolerated dose curve using drug combinations in cancer phase I clinical trialsMourad Tighiouart, Quanlin Li, André Rogatko
Statistics in Medicine|May 15, 2014
Dose finding with drug combinations in cancer phase I clinical trials using conditional escalation with overdose controlMourad Tighiouart, Steven Piantadosi, André Rogatko
Oral Oncology|April 9, 2008
Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanomaNicolas McLean, Mourad Tighiouart, Susan Muller
Stats|October 19, 2020
A Bayesian Adaptive Design in Cancer Phase I Trials Using Dose Combinations with Ordinal Toxicity GradesMárcio A Diniz, Sungjin Kim, Mourad Tighiouart
Pageof 13